» Articles » PMID: 25249296

Gait and Balance in Parkinson's Disease Subtypes: Objective Measures and Classification Considerations

Overview
Journal J Neurol
Specialty Neurology
Date 2014 Sep 25
PMID 25249296
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is often divided into tremor dominant (TD) and postural instability gait difficulty (PIGD) subtypes. However, objective measures of gait (e.g., stride length, variability) and balance have not been well studied in these subtypes. To better understand these motor subtypes, we objectively quantified gait and balance and their behavioral correlates. 110 patients with PD underwent a clinical evaluation and were stratified into PIGD and TD subtypes. Participants walked under single and dual task conditions while wearing a single body-fixed sensor, both "OFF" and "ON" medications and at home for 3 days. We also examined performance-based tests of mobility, balance, and fall risk. Stricter criteria were also applied, dividing the subjects into predominant representative subgroups: p-PIGD and p-TD. Both the PIGD (n = 62) and TD (n = 42) groups and the p-PIGD (n = 31) and p-TD (n = 32) subgroups were similar with respect to basic disease characteristics (e.g., disease duration, p > 0.69). Surprisingly gait speed, stride length, and variability did not differ between the PIGD and TD groups (p > 0.05). In contrast, the p-PIGD group had reduced gait speed (under single and dual task conditions), shorter strides, increased stride variability, and decreased stride regularity (regularity: p-PIGD 0.66 ± 0.10; p-TD 0.74 ± 0.08; p = 0.003). The p-PIGD group also scored worse on performance-based tests, compared to the p-TD. Clinical assessments of the disturbances seen in patients with the PIGD subtype are not consistent with objective measures; overlapping between the groups is seen in many objective features of gait and balance. These findings suggest that the proposed alternate classification scheme may be useful.

Citing Articles

Machine Learning and Statistical Analyses of Sensor Data Reveal Variability Between Repeated Trials in Parkinson's Disease Mobility Assessments.

Khalil R, Shulman L, Gruber-Baldini A, Shakya S, Hausdorff J, von Coelln R Sensors (Basel). 2025; 24(24.

PMID: 39771832 PMC: 11678965. DOI: 10.3390/s24248096.


Clinical and device-based predictors of improved experience of activities of daily living after a multidisciplinary inpatient treatment for people with Parkinson's disease: a cohort study.

Oppermann J, Tschentscher V, Welzel J, Geritz J, Hansen C, Gold R Ther Adv Neurol Disord. 2024; 17:17562864241277157.

PMID: 39328922 PMC: 11425784. DOI: 10.1177/17562864241277157.


The Effects of Multidisciplinary Intensive Rehabilitation on Cognitive and Executive Functions in Parkinson's Disease: A Clinical Database Analysis.

Baldassarre I, Rotondo R, Piccardi L, Leonardi L, Lanni D, Gaglione M J Clin Med. 2024; 13(13).

PMID: 38999450 PMC: 11242624. DOI: 10.3390/jcm13133884.


Electromyographic Characteristics of Postactivation Effect in Dopamine-Dependent Spectrum Models Observed in Parkinson's Disease and Schizophrenia.

Meigal A, Gerasimova-Meigal L, Kuzmina A, Antonen E, Peskova A, Burkin M Biomedicines. 2024; 12(6).

PMID: 38927545 PMC: 11202052. DOI: 10.3390/biomedicines12061338.


Wearable sensor-based quantitative gait analysis in Parkinson's disease patients with different motor subtypes.

Zhang W, Ling Y, Chen Z, Ren K, Chen S, Huang P NPJ Digit Med. 2024; 7(1):169.

PMID: 38926552 PMC: 11208588. DOI: 10.1038/s41746-024-01163-z.


References
1.
Weiss A, Herman T, Giladi N, Hausdorff J . Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days. PLoS One. 2014; 9(5):e96675. PMC: 4011791. DOI: 10.1371/journal.pone.0096675. View

2.
Podsiadlo D, Richardson S . The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39(2):142-8. DOI: 10.1111/j.1532-5415.1991.tb01616.x. View

3.
Graham J, Sagar H . A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord. 1999; 14(1):10-20. DOI: 10.1002/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4. View

4.
Mirelman A, Gurevich T, Giladi N, Bar-Shira A, Orr-Urtreger A, Hausdorff J . Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol. 2011; 69(1):193-7. DOI: 10.1002/ana.22165. View

5.
Herman T, Rosenberg-Katz K, Jacob Y, Giladi N, Hausdorff J . Gray matter atrophy and freezing of gait in Parkinson's disease: Is the evidence black-on-white?. Mov Disord. 2013; 29(1):134-9. DOI: 10.1002/mds.25697. View